A greater expression of IL-9 was identified within (peripheral blood mononuclear cells (PBMCs) from B-CLL patients compared to controls, and the levels were correlated with β2 microglobulin expression and immunoglobulin heavy variable group (IgVH) status. This evidence concerns the gene IL9 and B-cell chronic lymphocytic leukemia.